Investors
Healthcare & medtech
Low confidence
Updated model
Illustrative case study · The outcome shown is a modeled decision, not a measured client result.
Who needed the answer
A healthcare analyst on an investment research team. The model forecast a 23% rise in robotic knee replacements at US surgery centers this year.
Why they needed help
The forecast drove a position, and public procedure data lags by about a year.
What they asked
Our model forecasts a 23% rise in robotic knee replacements at US surgery centers this year. Do you agree?
What the experts said
Surgeons put growth at 10–15%, not 23%
Experts said payer approval for outpatient robotic procedures is the bottleneck, with faster growth in the South and Southwest.
Sample responses
“Our robot volumes are up, but payer approval for outpatient cases is what sets the pace.”
Orthopedic surgeon, multi-site surgery center group, Southeast US
answer_id
ans_8ff34739
respondent_id
rsp_97bb176e
“In our market, 23% isn’t crazy. Nationally I’d be surprised.”
Surgery center administrator, Texas
answer_id
ans_2e2ac0ea
respondent_id
rsp_cecc36c5
Illustrative quotes. In the product, every answer carries an answer_id and a respondent_id. The answer_id links to the full response and when it was given; the respondent_id links to the expert’s screened profile without revealing who they are, so any number can be traced back to its source.
About the experts and method
Who answered
Orthopedic surgeons and surgery-center administrators; licenses verified
Responses
All 7 answered · 6 disagree · 1 unsure
Safeguards
No clinical-trial investigators or advisers to listed device makers; no patient data
Business impact
From the findings via Ask Synquery Connector, the team decided to cut the national forecast to 12%.
The team keeps a higher case for the South and Southwest and tracks payer approval speed as a model input.